Cenk Sumen

Cenk Sumen

Plus aucun poste en cours
53 ans
Health Technology
Health Services
Consumer Services

Profil

Cenk Sumen worked as a Director at Thermo Fisher Scientific, Inc. and as a Senior Manager-Business Development at Minaris Regenerative Medicine LLC from 2014 to 2018.
He was also the Chief Scientific Officer at MaxCyte, Inc. from 2022 to 2024.
Currently, he is the Chief Technology Officer at Stemson Therapeutics, LLC.
Dr. Sumen received his undergraduate and doctorate degrees from Stanford University.

Anciens postes connus de Cenk Sumen

SociétésPosteFin
MAXCYTE, INC. Directeur Technique/Scientifique/R&D 23/01/2024
THERMO FISHER SCIENTIFIC, INC. Directeur/Membre du Conseil 01/04/2018
Corporate Officer/Principal 01/04/2018
Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Cenk Sumen

Formation de Cenk Sumen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

18

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées5

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Cenk Sumen
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT